Roche is a globally leading enterprise in pharmaceuticals. In Germany, Roche employs more than 15.600 people in 5 locations. Their work is focusing on pharmaceuticals and diagnostics, covering research and development, production and logistics, as well as marketing and distribution.
As it often occurs with INOSIM, the cooperation started in a consulting project. In this case, Roche Diagnostics at the Penzberg (Germany) location tested INOSIM Software in a pilot project. It featured the analysis of the consequences of expected amount increases in a multi-product multi-purpose factory. Therein, the simulation fulfilled the following tasks:
Based on INOSIM Software and Consulting Services, the Roche employees succeeded in generating a reality-true database to optimize the future production. This did not only convince the local project engineers, but also the operative management. By purchasing their own license of INOSIM Plant Edition, Roche will be able to conduct simulation projects by themselves, in the future. They are expecting to optimize the efficiency of the production as well as the plant performance.
Do you have any questions or would like to know more about this topic? Please contact us.
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from hCaptcha to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from hCaptcha to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information